Wyeth has announced that the jury in the case of Merle and Steven Simon v. Wyeth, in the Philadelphia Court of Common Pleas, found in favor of Wyeth.
The trial began on April 17, 2007, before The Honorable Nitza I. Quinones Alejandro. James Morris of the Texas firm Brent Coon & Associates and James J. Binns of the Pennsylvania firm James J. Binns, P.C., represented the plaintiffs.
"The evidence presented demonstrated that Wyeth acted responsibly by performing and supporting studies that examined the known and potential benefits and risks of hormone therapy and by keeping the U.S. Food and Drug Administration, physicians and patients informed of those benefits and risks," says Heidi K. Hubbard, a partner with Williams & Connolly LLP, a firm representing Wyeth in the case. "We believe the jury's decision as to Wyeth was consistent with the evidence presented and the body of scientific knowledge concerning hormone therapy."
Premarin (conjugated estrogens tablets USP) and Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) are approved by the U.S. Food and Drug Administration as safe and effective when used as indicated.